Rituxan (rituximab) - Roche
Oral Pemphigus in Children and Adolescents: A Narrative Review of Published Case Reports. (PubMed, Reports (MDPI)) - Sep 25, 2026 - "Systemic corticosteroids were the mainstay of treatment in conjunction with steroid sparing agents in some cases, with good results in difficult cases using rituximab...Early identification, diagnosis, and treatment through a collaborative approach from dental practitioners are critical. Further research is required at multiple centers to gain a better understanding of the disease and to develop evidence-based guidelines for diagnosis and treatment of pediatric patients." 
Journal • Review • Dental Disorders • Dermatology • Immunology • Pain • Pediatrics • Pemphigus Vulgaris
http://www.ncbi.nlm.nih.gov/pubmed/42784022
 
Athanasios Poulopoulos; Christina Charisi; Dorothea Pliaka; Efstratios Karagiannidis; Filippos Fytros; Konstantinos Poulopoulos; Maria Fasoula; Nikolaos Spantidakis; Panagiota Dimitropoulou; Vasileios Zisis
 
Sep 25, 2026
 
Prev Next